论文部分内容阅读
[方法]将46例随机分为两组,进行前瞻性对比治疗,治疗组(A组)23例,用康艾注射液联合化疗,对照组(B组)23例,单用化疗,两组所用化疗方案相同。[结果]治疗组和对照组近期总有效率按WHO标准分别为47.8%和39.1%(P>0.05),但生活质量评分A组提高率和下降率较B组均有显著性差异(P<0.05),免疫功能指标A组治疗前后下降不明显(P>0.05),B组下降明显(P<0.05),毒副反应治疗组较对照组明显少而轻(P<0.05)。[结论]中药康艾注射液联合化疗值得临床推广应用。
Methods: Forty-six patients were randomly divided into two groups. The patients in treatment group (A group) were treated with Kangai injection combined with chemotherapy, and 23 patients in control group (B group) The same chemotherapy used. [Results] The total effective rates of the treatment group and the control group were 47.8% and 39.1% respectively (P> 0.05), but the improvement rate and decline rate of the A group were significantly lower than those of the B group (P < 0.05). There was no significant difference in immune function between the two groups before and after treatment (P> 0.05). The level of immune function decreased significantly in group B (P <0.05). [Conclusion] Chinese medicine Kangai injection combined with chemotherapy worth of clinical application.